Turning Open Source Developers Into Superfans
In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform…
In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform…
CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be…
We’re living in an unprecedented era of online collaboration, coordination, and creation. All kinds of people are coming together — whether in an open source project or company,…
In this episode — cross posted from our 16 Minutes show feed — we cover all the buzz around GPT-3, the pre-trained machine learning model from OpenAI that’s…
Many don’t realize we even need to think about the possibility of security hacks when it comes to things like pacemakers, insulin pumps, and more. But when bits…
Ever since the discovery of antibiotics, microbiologists have worried about and studied how bacteria acquire resistance to these drugs. Adding to the complexity of this problem is the…
A dive into the sociological, operational, and tactical realities of this murky underworld, Lusthaus and de la Garza discuss who the players are, what they are motivated by,…
Dr. Marty Makary—surgical oncologist at Johns Hopkins University School of Medicine, and health policy and innovation expert—has long been a passionate advocate for transparent pricing in the healthcare…
More than 98% of the information on the web is lost within 20 years, and huge gaps exist in our digital and cultural history. Zoran Basich and Alex…
In part 1 of our series on human performance, we looked at the limits of human potential in climbing and other sports – and how we push those…
Nothing left to load.